Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Item
http://www.wikidata.org/entity/Q41098795
Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapyInfliximab-Associated Psoriasiform Dermatitis: Case Report and Review of a Seemingly Paradoxical Inflammatory Response.A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.Adverse Events During Anti-TNFα Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience.Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.Clinical Signs, Pathophysiology and Management of Cutaneous Side Effects of Anti-Tumor Necrosis Factor Agents.Novel posterior auricular cutaneous reaction after anti-TNF-α infusion in young women with Crohn's disease.Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.Tumour necrosis factor-α-inhibitor-induced neutrophilic folliculitis presenting with strong lesional expression of interleukin-36γ.Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients.Cholinergic Anti-Inflammatory Pathway Does Not Contribute to Prevention of Ulcerative Colitis by Novel Indoline Carbamates.New onset vitiligo following commencement of infliximab in Crohn disease.
P2860

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Item
http://www.wikidata.org/entity/Q41098795
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cumulative incidence of, risk ...... disease: a 14-year experience.
@en
type
label
Cumulative incidence of, risk ...... disease: a 14-year experience.
@en
prefLabel
Cumulative incidence of, risk ...... disease: a 14-year experience.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Cumulative incidence of, risk ...... disease: a 14-year experience.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921